Drugs / Lanthanum carbonate (chewed vs. crushed)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00458289 Comparator | Jan 2007 → Jun 2008 | hyperphosphatemia | University of Illinois at Chicago | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lanthanum carbonate (chewed vs. crushed) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00458289 ↗ |
| Route | Oral | “single 1 g oral dose of lanthanum carbonate either chewed or crushed into a fine powder” NCT00458289 ↗ |